EPSTEIN-BARR VIRUS-INDUCED AUTOIMMUNE RESPONSES .2. IMMUNOGLOBULIN-G AUTOANTIBODIES TO MIMICKING AND NONMIMICKING EPITOPES - PRESENCE IN AUTOIMMUNE-DISEASE

被引:56
作者
VAUGHAN, JH
NGUYEN, MD
VALBRACHT, JR
PATRICK, K
RHODES, GH
机构
[1] UNIV CALIF SAN DIEGO,SAM & ROSE STEIN INST RES AGING,LA JOLLA,CA 92093
[2] SAN DIEGO STATE UNIV,STUDENT HLTH SERV,SAN DIEGO,CA 92182
[3] VICAL CORP,SAN DIEGO,CA 92121
关键词
AUTOIMMUNITY; EPITOPE; VIRUS; SCLERODERMA; LUPUS ERYTHEMATOSUS;
D O I
10.1172/JCI117782
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
During infectious mononucleosis, IgM autoantibodies are generated to a protein, p542, which contains a glycine-rich 28-mer epitope cross-reactive with the Epstein-Barr nuclear antigen-1 through Epstein-Barr nuclear antigen-1's glycine/alanine repeat. In normal individuals it is uncommon to find IgG anti-p542, but among patients with progressive systemic sclerosis, systemic lupus erythematosus, and ulcerative colitis high IgG anti-p542 (>3 SD above the mean of normal 20-50 yr controls) occurred frequently. Lesser elevations occurred in Sjogren's syndrome, rheumatoid arthritis, ankylosing spondylitis, and Crohn's disease, but none with chronic hepatitis B infection. The reactive epitopes on p542 were mapped with deletion mutants, which indicated that the glycine-rich 28-mer was the major antigenic determinant, with lesser antibody responses to other epitopes. We conclude that normally there is an inability to generate IgG autoantibodies to the cross-reactive (mimicking) epitope of the p542 host protein, but that this inability is overcome in a proportion of patients with autoimmune disease. We conclude also that non-cross-reactive autoepitopes exist on p542 protein, to which IgG autoantibodies can commonly be formed in autoimmune disorders. The mechanisms responsible for the latter must involve different mechanisms than those responsible for autoantibodies to the mimicking epitope.
引用
收藏
页码:1316 / 1327
页数:12
相关论文
共 47 条
[1]   INDUCTION OF SELF-TOLERANCE IN T-CELLS BUT NOT B-CELLS OF TRANSGENIC MICE EXPRESSING LITTLE SELF ANTIGEN [J].
ADELSTEIN, S ;
PRITCHARDBRISCOE, H ;
ANDERSON, TA ;
CROSBIE, J ;
GAMMON, G ;
LOBLAY, RH ;
BASTEN, A ;
GOODNOW, CC .
SCIENCE, 1991, 251 (4998) :1223-1225
[2]   CDNA CLONING AND SEQUENCING OF HUMAN FIBRILLARIN, A CONSERVED NUCLEOLAR PROTEIN RECOGNIZED BY AUTOIMMUNE ANTISERA [J].
ARIS, JP ;
BLOBEL, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (03) :931-935
[3]   POLYMORPHISM OF THE EBNA RANA ANTIGEN IN EPSTEIN-BARR VIRUS-POSITIVE CELL-LINES [J].
BILLINGS, PB ;
HOCH, SO ;
VAUGHAN, JH .
ARTHRITIS AND RHEUMATISM, 1984, 27 (12) :1423-1427
[4]   ANALYSIS OF AUTOANTIBODIES TO RECOMBINANT LA (SS-B) PEPTIDES IN SYSTEMIC LUPUS-ERYTHEMATOSUS AND PRIMARY SJOGRENS SYNDROME [J].
BINI, P ;
CHU, JL ;
OKOLO, C ;
ELKON, K .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (02) :325-333
[5]   ANTIBODIES AGAINST EPSTEIN-BARR NUCLEAR ANTIGEN (EBNA) IN MULTIPLE-SCLEROSIS CSF, AND 2 PENTAPEPTIDE SEQUENCE IDENTITIES BETWEEN EBNA AND MYELIN BASIC-PROTEIN [J].
BRAY, PF ;
LUKA, J ;
BRAY, PF ;
CULP, KW ;
SCHLIGHT, JP .
NEUROLOGY, 1992, 42 (09) :1798-1804
[6]   ROLE OF A MAJOR AUTOEPITOPE IN FORMING THE DNA-BINDING SITE OF THE P70 (KU) ANTIGEN [J].
CHOU, CH ;
WANG, JS ;
KNUTH, MW ;
REEVES, WH .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (06) :1677-1684
[7]  
DANG H, 1985, J IMMUNOL, V134, P3825
[8]  
Epstein MA, 1979, EPSTEIN BARR VIRUS
[9]  
FARMER GW, 1973, GASTROENTEROLOGY, V65, P8
[10]  
FRANCOEUR AM, 1986, J IMMUNOL, V136, P1648